Neonatal Diabetes Mellitus: Understanding Transient and Permanent Forms
Author Information
Author(s): Michel Polak, Hélène Cavé
Primary Institution: Faculty of medicine Paris René Descartes, Paediatric endocrinology and INSERM U845, Hôpital Necker-Enfants Malades, Paris, France
Hypothesis
What are the molecular mechanisms and clinical features distinguishing transient neonatal diabetes mellitus (TNDM) from permanent neonatal diabetes mellitus (PNDM)?
Conclusion
Neonatal diabetes can be classified into transient and permanent forms, with distinct clinical features and genetic causes, leading to different treatment approaches.
Supporting Evidence
- TNDM represents 50% to 60% of cases of neonatal diabetes.
- Patients with TNDM are more likely to have intrauterine growth retardation.
- Genetic mutations in KCNJ11 and ABCC8 account for a significant proportion of PNDM cases.
- Clinical features of TNDM and PNDM overlap, making diagnosis challenging.
- Prolonged follow-up is essential for patients with TNDM due to the risk of recurrence.
Takeaway
Neonatal diabetes is a rare condition that can either go away on its own or last a lifetime, and understanding the differences helps doctors treat it better.
Methodology
The study involved clinical descriptions, molecular analysis of genetic mutations, and comparisons of clinical features between TNDM and PNDM patients.
Potential Biases
Potential bias in patient selection and reporting of clinical features.
Limitations
The study may not cover all genetic causes of neonatal diabetes and relies on available cohorts.
Participant Demographics
The study included a cohort of 50 patients with neonatal diabetes, with varying ages and clinical presentations.
Statistical Information
P-Value
p<0.006
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website